新闻

• Apellis to Showcase Leadership in Retina at Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
  16.04.2021 / 18:44 - GlobeNewswire
•  
• Adverum Biotechnologies to Present New Data from the OPTIC Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at ARVO 2021 
  16.04.2021 / 14:05 - GlobeNewswire
•  
• AMD to Report Fiscal First Quarter 2021 Financial Results
  15.04.2021 / 22:15 - GlobeNewswire
•  
• Dow closes above 34,000 pts, Nasdaq at record closing high
  15.04.2021 / 22:01 - TeleTrader
•  
• Adverum Files Definitive Proxy Materials and Mails Letter to Stockholders Detailing Strength of Team and Acceleration Toward Commercialization of ADVM-022
  15.04.2021 / 14:00 - GlobeNewswire
•  
• CORSAIR Launches New AMD Ryzen™ 5000-Series Powered CORSAIR ONE a200 and 11th Gen Intel® Core™-Powered CORSAIR ONE i200 Gaming PCs
  13.04.2021 / 15:00 - GlobeNewswire
•  
• Apellis Provides 24-Month Update from Phase 1b Study of Pegcetacoplan in Patients with Geographic Atrophy
  13.04.2021 / 13:00 - GlobeNewswire
•  
• OXURION NV to Present at Wet AMD and DME Drug Development Summit
  13.04.2021 / 07:30 - GlobeNewswire
•  
• AMD and Xilinx Stockholders Overwhelmingly Approve AMD’s Acquisition of Xilinx
  07.04.2021 / 18:49 - GlobeNewswire
•  
• Oxurion NV – Publication in Progress in Retinal Eye Research highlights the potential of pan-RGD integrin antagonists to improve the treatment of diabetic retinopathy and wet AMD
  07.04.2021 / 17:45 - GlobeNewswire
•  
• Pixium Vision announces first patient successful implantation in Prima System pivotal trial PRIMAvera
  07.04.2021 / 07:00 - GlobeNewswire
•  
• ForeseeHome AMD home monitoring real-world data analysis demonstrates substantial benefit for patients’ vision
  06.04.2021 / 14:00 - GlobeNewswire
•  
• Opthea Company Secretary Resignation
  06.04.2021 / 11:30 - GlobeNewswire
•  
• Oxurion NV enters into a Capital Commitment of up to €30 Million with Negma Group
  06.04.2021 / 07:30 - GlobeNewswire
•  
• Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD & DME Drug Development Summit
  05.04.2021 / 13:05 - GlobeNewswire